QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Garth Richmond who wrote (935)	7/7/2000 12:25:38 PM
From: Ian@SI	Read Replies (1) of 1321

Garth, MRVT is old news; still in Phase III trial; and still about 2 years away from an FDA approval. If I were looking for reasons for QLT's price fluctuations, I'd start with news directly pertinent to QLT; then what's happening in the Biotech sector; then what's been happening to the market rather than attempting to speculate on some improbable scenario. I have a small MRVT position - just enough to keep me following news on that company. IMO, QLT is the hands down winner in this segment. Ian.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next